Medicare Enrolled

Dr. Andrew Krouner, M.D.

Ophthalmology · Wexford, PA
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
7000 STONEWOOD DR, Wexford, PA 15090
7249404001
In practice since 2006 (19 years)
NPI: 1740294255 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Krouner from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Krouner? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Krouner

Dr. Andrew Krouner is an ophthalmology specialist in Wexford, PA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Krouner performed 2,815 Medicare services across 2,222 unique beneficiaries.

Between the years covered by Open Payments, Dr. Krouner received a total of $2,374 from 24 pharmaceutical and/or device companies across 104 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in ophthalmology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Krouner is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 33% volume in PA $2,374 industry payments

Medicare Practice Summary

Medicare Utilization ↗
2,815
Medicare services
Top 33% in PA for ophthalmology
2,222
Unique beneficiaries
$68
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~148 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Comprehensive eye exam, established patient
A comprehensive examination of the visual system performed for a patient who has previously been seen by the provider.
1,179 $82 $240
Eye exam, established patient, focused
A limited examination of the visual system for an existing patient. The provider focuses on a specific eye-related concern or symptom.
468 $60 $166
Optic nerve imaging (OCT scan)
Imaging of the optic nerve.
282 $24 $86
Microfluid analysis of tears
A laboratory test that analyzes tear fluid using microfluidic technology to measure specific biomarkers. This procedure helps evaluate the composition of tears for diagnostic purposes.
232 $22 $40
Visual field test, extended
A test that maps your complete field of vision to detect blind spots or peripheral vision loss. Extended testing provides a more detailed assessment than a standard visual field exam.
193 $40 $126
Retinal imaging (OCT scan)
This procedure involves imaging the retina to visualize its structure. It is used to examine the back of the eye.
125 $25 $88
Laser removal of recurring cataract
A laser procedure to remove a recurring cataract within the lens capsule.
91 $249 $649
Immunoassay substance analysis, multiple step method
A laboratory test that uses an immunoassay technique to analyze a substance. The process involves multiple steps to detect or measure the target material.
88 $11 $31
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
70 $98 $313
Laser eye fluid drainage tract creation
A laser procedure used to create drainage tracts in the iris to help fluid flow out of the eye.
44 $207 $582
Comprehensive eye exam, new patient
A comprehensive examination of the visual system performed for a new patient.
43 $79 $289
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$2,374
Total received (2018-2024)
Avg $339/year across 7 years
Top 33% in PA for ophthalmology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
24
Companies
104
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$2,350 (99.0%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$23 (1.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$600
2023
$257
2022
$391
2021
$247
2020
$196
2019
$265
2018
$419

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Astellas Pharma US Inc
$261
Oyster Point Pharma, Inc.
$155
ABBVIE INC.
$66
Alcon Vision LLC
$39
Tarsus Pharmaceuticals, Inc.
$39
Bausch & Lomb Americas Inc.
$19
LENSAR, Inc.
$19
Top 3 companies account for 80.5% of 2024 payments
All-time payments by company (2018-2024) ›
Novartis Pharmaceuticals Corporation
$381
Allergan Inc.
$293
Oyster Point Pharma, Inc.
$282
Astellas Pharma US Inc
$261
Sun Pharmaceutical Industries Inc.
$166
Alcon Vision LLC
$120
Mallinckrodt Enterprises LLC
$106
Regeneron Healthcare Solutions, Inc.
$100
Bausch & Lomb, a division of Bausch Health US, LLC
$100
ABBVIE INC.
$93
Mallinckrodt Hospital Products Inc.
$73
Bausch & Lomb Americas Inc.
$71
Shire North American Group Inc
$63
Kala Pharmaceuticals, Inc.
$40
Tarsus Pharmaceuticals, Inc.
$39
Quidel Corporation
$29
TISSUETECH, INC.
$28
Alimera Sciences, Inc.
$26
SUN PHARMACEUTICAL INDUSTRIES INC.
$24
Ocular Therapeutix, Inc.
$20
LENSAR, Inc.
$19
NovaBay Pharmaceuticals, Inc.
$18
Mallinckrodt LLC
$12
TissueTech, Inc.
$10
Top 3 companies account for 40.3% of all-time payments
Associated products mentioned in payments ›
ACTHAR · Avenova · BEOVU · BESIVANCE · CEQUA · COMBIGAN · Cequa · DEXTENZA · EYLEA · EYSUVIS · Eye Health · ILUVIEN · ILUX · INVELTYS · Izervay · LENSAR LASER SYSTEM · LOTEMAX SM · LUMIGAN · OZURDEX · PROKERA · PROLENSA · Prokera · RESTASIS · Rocklatan · Simbrinza · TYRVAYA · VYZULTA · XDEMVY · XIIDRA · ZYLET
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for an ophthalmology specialist in Wexford?
Compare ophthalmologists in the Wexford area by procedure volume, costs, and industry payment transparency.
Browse ophthalmologists nearby

Geographic Context

Ophthalmologists within 10 mi
184
Per 100K population
14.8
County median income
$76,393
Nearest hospital
AHN WEXFORD HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Krouner is a mixed practice specialist, with moderate Medicare volume, with low-engagement industry engagement, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Krouner experienced with comprehensive eye exam, established patient?
Based on Medicare claims data, Dr. Krouner performed 1,179 comprehensive eye exam, established patient services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Krouner receive payments from pharmaceutical companies?
Yes. Dr. Krouner received a total of $2,374 from 24 companies across 104 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Krouner's costs compare to other ophthalmologists in Wexford?
Dr. Krouner's average Medicare payment per service is $68. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Krouner) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →